AACP
MD icon

Advantage Alpha Capital Partners’s Pediatrix Medical MD Stock Holding History

Advantage Alpha Capital Partners’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-126,074
Closed -$3.5M – 97
2019
Q4 		$3.5M Buy
+126,074
New +$3.16M 0.95% 54

Other funds holding MD

ACH
ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SV
Starboard Value New York $4.52B AUM 19.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
PCP
P2 Capital Partners New York $246M AUM 17.67% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Advantage Alpha Capital Partners's MD Position: Q1 2020 in Review

Advantage Alpha Capital Partners sold out of Pediatrix Medical (MD) in Q1 2020, closing a stake of 126,074 shares — an estimated $3.5M sold.

Advantage Alpha Capital Partners first reported a position in MD in Q4 2019 and held it in 1 quarter. The position peaked at $3.5M in Q4 2019. 221 funds tracked by Wall St. Rank hold MD as of Q1 2020.

  • Advantage Alpha Capital Partners reported no remaining Pediatrix Medical position as of Q1 2020 after selling out during the quarter.
  • Advantage Alpha Capital Partners sold 126,074 Pediatrix Medical shares in Q1 2020, an estimated $3.5M.
  • Advantage Alpha Capital Partners first reported a position in Pediatrix Medical in Q4 2019 and held it in 1 quarter.
  • Advantage Alpha Capital Partners's Pediatrix Medical position peaked at $3.5M in Q4 2019.
  • 221 funds tracked by Wall St. Rank held Pediatrix Medical as of Q1 2020.

Based on Advantage Alpha Capital Partners's 13F filing for Q1 2020, filed 15 May 2020.